|
Inhaled and Intranasal Products Contract Service Providers Market, 2030
Tuesday, December 15, 2020
DUBLIN, Dec. 7, 2020 /PRNewswire/ -- The "Inhaled and Intranasal Products Contract Service Providers Market, 2020-2030" report has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
The 'Inhaled and Intranasal Products: Contract Service Providers Market (Focus on Drugs and Drug Delivery Systems), 2020 - 2030' report features an extensive study of the current market landscape and future opportunities for the contract service providers focused on drugs and drug delivery systems. It features an in-depth analysis, highlighting the capabilities of various contract service providers engaged in this domain.
One of the key objectives of the report was to understand the primary growth drivers and estimate the future size of the market. Based on parameters, such as overall pulmonary market, global intranasal drug market, cost of goods sold and outsourcing trends, we have provided an informed estimate of the likely evolution of the contract service providers market in the mid to long term, for the time period 2020-2030.
Amongst other elements, the report includes:
-- A detailed assessment of the overall landscape of companies offering
contract and custom services for the inhaled and Intranasal drug
development and manufacturing, along with information on a number of
relevant parameters, such as year of establishment, company size, type
of service provider (contract manufacturing organization and contract
research organization), scale of operation (preclinical, clinical and
commercial), location of headquarters, location of manufacturing
facilities, type of drug molecule (small molecule and biologic), type of
inhaled and intranasal related primary service(s) offered (development,
manufacturing, analytical testing/services, device
selection/optimization and fill/finish and packaging), type of inhaled
and intranasal related secondary service(s) offered (process
development, pre-formulation development, formulation development,
pre-formulation manufacturing, formulation manufacturing, particle
engineering, product characterization, extractable and leachable
studies, stability testing and plume geometry measurement), type of
formulation (powder, aerosol and liquid), type of dosage form (metered
dose inhaler, dry powder inhaler, nebulizer, soft mist inhaler, nasal
spray, nasal drops, nasal powder and others), route of administration
(oral and intranasal inhalation) and installed capacity and batch size
(if available).
-- A detailed assessment of the overall landscape of the companies offering
contract services for the inhaled and intranasal drug delivery system
manufacturing, along with information on a number of relevant
parameters, such as year of establishment, company size, scale of
operation (precommercial and commercial), location of headquarters,
location of manufacturing facilities, type of inhaled and intranasal
drug delivery system related service(s) offered (design, development,
manufacturing, assembly, fill/finish and packaging), type of formulation
(powder, aerosol and liquid) and type of drug delivery system used
(metered dose inhaler, dry powder inhaler, nebulizer, nasal spray and
others).
-- A competitiveness analysis of inhaled and intranasal drug product
contract service providers across key geographical areas, featuring a
four-dimensional bubble representation, taking into consideration
service strength (number of services offered, type of formulation(s)
offered and route of administration), manufacturing strength (type of
drug molecule, scale of operation, number of manufacturing facilities),
supplier strength (company size and its experience in this field) and
company size (small-sized, mid-sized and large).
-- Tabulated profiles of some of the key contract manufacturers
(shortlisted based on a proprietary criterion) that offer a diverse
range of capabilities for the development, manufacturing and packaging
of inhaled and intranasal drugs across North America, Europe and
Asia-Pacific. Each profile features an overview of the company, along
with information related to its financial performance (if available),
service portfolio, products and intranasal related capabilities, type of
drug molecule, type of dosage form, inhaled and intranasal products
related manufacturing facilities, recent developments and an informed
future outlook.
-- An analysis of the various partnerships related to inhaled and
intranasal contract service providers, which have been established since
2015, based on several parameters, such as year of agreement, type of
partnership (development agreements, manufacturing agreements, merger
and acquisition, licensing agreement, commercialization, research and
development agreements, service alliance, joint venture and other
agreements), scale of operation (preclinical, clinical and commercial),
type of inhaled and intranasal related service(s) offered (development,
manufacturing, analytical testing/services and fill/finish and
packaging), type of dosage form (metered dose inhalers, dry powder
inhalers, nebulizers and others) and most active players. It also
provides the regional distribution of the players involved in the
collaborations.
-- A qualitative analysis highlighting the various factors that need to be
taken into consideration by inhaled and intranasal product developers,
while deciding whether to manufacture their respective products in-house
or engage a contract service provider.
-- An estimate of the global, inhaled and intranasal product demand, based
on the type of product (inhaled and intranasal), type of drug delivery
system used (metered dose inhalers, dry powder inhalers, nebulizers and
nasal sprays) and key geographical regions (North America, Europe and
Asia-Pacific).
-- An insightful discussion on the impact of COVID-19 outbreak on the
inhaled and intranasal service providers. In addition, it features
various strategies that different companies have adopted/may adopt in
order to mitigate the challenges affiliated to the current global
crisis.
Key Questions Answered
-- Who are the leading contract service providers offering inhalable and
intranasal products related services, across the world?
-- In which regions are majority of the inhaled and intranasal product
related manufacturing facilities located?
-- What percentage of inhaled and intranasal manufacturing operations are
outsourced?
-- Which partnership models are commonly adopted by stakeholders in this
industry?
-- What is the impact of COVID-19 outbreak on inhaled and intranasal
product services market?
-- What is the current, global demand for inhaled and intranasal products?
-- How is the current and future market opportunity likely to be
distributed across key market segments?
Key Topics Covered:
1. Preface
2. Executive Summary
3. Introduction
4. Inhaled And Intranasal Drug Product Service Providers: Market Landscape
5. Inhaled And Intranasal Drug Delivery System Manufacturing Service Providers: Market Landscape
6. Company Competitiveness Analysis
7. Inhaled And Intranasal Contract Manufacturing Service Providers In North America
8. Inhaled And Intranasal Contract Manufacturing Service Providers In Europe And Asia-Pacific
9. Partnerships And Collaborations
10. Make Versus Buy Decision Making
11. Demand Analysis
12. Market Forecast And Opportunity Analysis
13. Impact Of Covid-19 Pandemic On The Inhaled And Intranasal Service Providers Market
14. Conclusion
15. Executive Insights
16. Appendix 1: Tabulated Data
Companies Mentioned
-- 3M
-- 3P innovation
-- Actelion Pharmaceuticals
-- Aerami Therapeutics (formerly Dance Biopharm)
-- Aerosol Research and Engineering Laboratories
-- Akums Drugs & Pharmaceuticals
-- Alcami
-- Alpic Biotech
-- Altaris Capital Partners
-- Altimmune
-- Amneal Pharmaceuticals
-- Aptar Pharma
-- Arch Biopartners
-- Arcturus Therapeutics
-- ASM Aerosol-Service
-- Aspen Pharmacare
-- AstraZeneca
-- Atossa Therapeutics
-- Aurohealth
-- Basic Pharma
-- Battelle
-- Bespak
-- Beximco Pharmaceuticals
-- BioCare Group
-- Biofilms Research Center for Biointerfaces, Malmo University
-- Boehringer Ingelheim
-- Breath Therapeutics
-- Capsugel
-- Carclo Technical Plastics
-- Catalent
-- CF PharmTech
-- Charles River Laboratories
-- Chemic Laboratories
-- Chiesi Farmaceutici
-- Chromcore Lifesciences
-- Cirrus Pharmaceuticals
-- COC Farmaceutici
-- Colep
-- Confab
-- Consort Medical
-- Contract Pharmaceuticals
-- Creative Biolabs
-- Circassia
-- CrystecPharma
-- Curida
-- CytoAgents
-- Dalton Pharma Services
-- DFE Pharma
-- Doctor Pack
-- Dorizoe Lifesciences
-- DPT Laboratories
-- Dr. Reddy's Laboratories
-- DRK Pharma Solutions
-- Dwarkesh Pharmaceuticals
-- EKG Life Science Solutions
-- Elfin Drugs
-- Emmace Consulting
-- Ennaid Therapeutics
-- Ethris
-- Eurofins
-- Evoke Pharma
-- Evonik
-- Experic
-- Farbe Firma
-- FAMAR
-- Focus Inhalation
-- Forefront Medical Technology
-- Forest Laboratories
-- Genentech
-- Gerresheimer
-- Getron Pharmaceuticals
-- Gilead Sciences
-- GlaxoSmithKline
-- Global Pharma
-- Hikma Pharmaceuticals
-- Horizon Pharmaceuticals
-- Hovione
-- Humanigen
-- Iconovo
-- IIT Research Institute (IITRI)
-- Impopharma
-- Importfab
-- Inhalexpert
-- InhaTarget Therapeutics
-- Insmed
-- Intas Pharmaceuticals
-- Intertek
-- Invion
-- iPharma
-- ITC Farma
-- J Pharmaceuticals
-- Jabil
-- Jagotec
-- Janssen Pharmaceuticals
-- Johnson & Johnson
-- Kiel University
-- Kindeva Drug Delivery
-- King's College London
-- Kymos Pharma Services
-- Labiana Pharmaceuticals
-- Lamda Laboratories
-- Lannet Technologies
-- LEAX Group
-- Lepharm
-- Life Vision Healthcare
-- Lindal Group
-- Liquidia Technologies
-- Lomapharm
-- Lonza
-- Lovelace Biomedical
-- Lxir Medilabs (A unit of SMM Life Sciences)
-- M2M Pharmaceuticals
-- Macter International
-- Malmo University
-- MannKind
-- Mapaex
-- Maya Biotech
-- McMaster University
-- Medicair Bioscience Laboratories
-- Medicilon
-- Medlab Pharmaceuticals
-- MedPharm
-- Menarini Group
-- Merck
-- Micro-Sphere
-- MidasCare
-- Mipharm
-- MMG Healthcare
-- Moderna Therapeutics
-- Molex
-- Medicon Valley Inhalation Consortium (MVIC)
-- Mylan
-- Nanologica
-- Nanopharm
-- Napp Pharmaceuticals
-- Nelipak Healthcare Packaging
-- Nelson Laboratories
-- Nemera
-- Nephron Pharmaceuticals
-- Neurelis
-- Neurimmune
-- Newtec Pro Manufacturing
-- Next Breath
-- Nipro
-- Nitto Medic
-- Nivon Specialties
-- Noble
-- Novartis
-- One Pharma
-- Orion
-- Ote Pharma
-- Optinose
-- Paragon Nordic
-- PARI Pharma
-- PCI Pharma Services
-- Penta Arzneimittel
-- Pfizer
-- Pharma Stulln
-- Pharma Tech
-- PharmaCielo
-- Pharmaserve
-- Pharmaterials
-- PHAST (Acquired by Eurofins)
-- Phillips-Medisize
-- Pine Lake Laboratories
-- Polyphor
-- PPD Laboratories
-- Probiotec
-- Propeller Health
-- Proveris Scientific
-- Pulmatrix
-- PulmoFlow
-- Pursuit Pharma
-- Pushkar Pharma
-- Quotient Sciences
-- Recipharm
-- Renaissance Pharmaceuticals
-- Roche
-- Rommelag
-- Rubicon Research
-- S.R.Chemicals and Pharmaceuticals
-- SAFE Pharmaceutical
-- Salvat
-- Sandoz
-- Sanofi
-- Sciarra Laboratories
-- Seikagaku
-- Sentiss Pharma
-- Servier Pharmaceuticals
-- SHL Group
-- Simpler Consulting
-- SkyePharma
-- Smithers
-- Spicona
-- Stabicon Life Sciences
-- Stevanato Group
-- Summit Biosciences
-- Sunovion
-- Sunovion Pharmaceuticals
-- Synerlab
-- Takeda
-- Teva Pharmaceuticals
-- The Indian Pharmaceutical Association
-- The Ritedose Corporation
-- Theravance Biopharma
-- Tinuum
-- Toxikon
-- Trillium Health Care Products
-- UCB Pharma
-- Ultratech India
-- United Therapeutics
-- University of Birmingham
-- University of Copenhagen
-- University of Cyprus
-- University of Florida
-- University of Turku
-- Bausch Health (formerly Valeant Pharmaceuticals)
-- Vectura
-- ViralClear Pharmaceuticals (A subsidiary of BioSig Technologies)
-- Vinventions
-- Vivimed
-- West Coast Pharmaceutical
-- Westmed Medical Group
For more information about this report visit https://www.researchandmarkets.com/r/63lzod
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/inhaled-and-intranasal-products-contract-service-providers-market-2030-301187280.html
SOURCE Research and Markets
|
|
|
|
|
|
 |
Skunk Works® and XTEND Expand Joint All Domain Command and Control for Advanced Mission Execution | Jan 22, 2026
|
|
Sup AI Sets New Benchmark Record with 52.15% on Humanity's Last Exam | Jan 22, 2026
|
|
Weekly Recap: 11 Tech Press Releases You Need to See | Jan 22, 2026
|
|
Trigent Partners with WeWork India to Expand its GCC Footprint | Jan 22, 2026
|
|
DEADLINE ANNOUNCED FOR 2026 NEW TOP-LEVEL DOMAIN APPLICATIONS | Jan 22, 2026
|
|
Exia Labs Brings Keystone to the U.S. Navy via DIU's Blue Object Management Challenge | Jan 22, 2026
|
|
Genpact Named a Leader in ISG Provider Lens(TM) 2025 for Insurance GCCs and Agentic AI Services | Jan 22, 2026
|
|
Marketing Evolution Announces New Investment Led by Insight Partners to Power AI-Ready Marketing Data for the Agentic Era | Jan 22, 2026
|
|
Glasswall Brings Defense-Level File Sanitization to Every Government Agency and Business Using Microsoft 365 | Jan 22, 2026
|
|
Altair HyperWorks 2026 Delivers Design and Simulation at Scale with AI | Jan 22, 2026
|
|
|
|
